Sagent Pharmaceuticals Reports Data Incident in New Hampshire

Sagent Pharmaceuticals, a specialized healthcare company, officially reported a data security incident to the New Hampshire Attorney General's office on May 1, 2026. This disclosure indicates that unauthorized parties may have accessed the company's internal systems. The investigation into the full scope of this event is ongoing.

According to the filing, Sagent Pharmaceuticals identified a security event where internal systems were potentially compromised. While the specific nature of the intrusion and the exact date it occurred remain unknown, the company has initiated an investigation to understand the incident fully. This type of event typically prompts organizations to assess the integrity of their data systems.

Individuals who have received a formal data breach notification letter from Sagent Pharmaceuticals should understand that their personal information was likely part of the data accessed during this incident. The company's role in the healthcare supply chain means it handles various types of sensitive personal data. However, the precise categories of information involved in this specific security event have not been detailed in the public record.

If you have received a notification, it is important to carefully review the letter for any specific advice provided by Sagent Pharmaceuticals. As a general precaution, consider monitoring your accounts for unusual activity. This includes reviewing financial statements and any notifications related to your identity.

You may also consider placing a fraud alert or security freeze on your credit reports with the major credit bureaus. This can help prevent new accounts from being opened in your name without your authorization. Remain vigilant for unsolicited communications that request personal details, as these could be phishing attempts.